New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics
Top Cited Papers
Open Access
- 1 January 2013
- journal article
- review article
- Published by Hindawi Limited in Evidence-Based Complementary and Alternative Medicine
- Vol. 2013, 1-25
- https://doi.org/10.1155/2013/627375
Abstract
With tens of thousands of plant species on earth, we are endowed with an enormous wealth of medicinal remedies from Mother Nature. Natural products and their derivatives represent more than 50% of all the drugs in modern therapeutics. Because of the low success rate and huge capital investment need, the research and development of conventional drugs are very costly and difficult. Over the past few decades, researchers have focused on drug discovery from herbal medicines or botanical sources, an important group of complementary and alternative medicine (CAM) therapy. With a long history of herbal usage for the clinical management of a variety of diseases in indigenous cultures, the success rate of developing a new drug from herbal medicinal preparations should, in theory, be higher than that from chemical synthesis. While the endeavor for drug discovery from herbal medicines is “experience driven,” the search for a therapeutically useful synthetic drug, like “looking for a needle in a haystack,” is a daunting task. In this paper, we first illustrated various approaches of drug discovery from herbal medicines. Typical examples of successful drug discovery from botanical sources were given. In addition, problems in drug discovery from herbal medicines were described and possible solutions were proposed. The prospect of drug discovery from herbal medicines in the postgenomic era was made with the provision of future directions in this area of drug development.Keywords
Funding Information
- National Natural Science Foundation of China (31071989, 201006)
This publication has 149 references indexed in Scilit:
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's diseaseNature Genetics, 2011
- Tomatoes, lycopene-containing foods and cancer riskBritish Journal of Cancer, 2011
- PubChem as a public resource for drug discoveryDrug Discovery Today, 2010
- Systems PharmacologyMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010
- Next‐generation antimalarial drugs: hybrid molecules as a new strategy in drug designDrug Development Research, 2009
- Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccinesVaccine, 2009
- Pharmacology of Schisandra chinensis Bail.: An overview of Russian research and uses in medicineJournal of Ethnopharmacology, 2008
- Natural Products as Sources of New Drugs over the Last 25 YearsJournal of Natural Products, 2007
- Production of the antimalarial drug precursor artemisinic acid in engineered yeastNature, 2006
- 1,026 Experimental treatments in acute strokeAnnals of Neurology, 2006